Biggest changeThe percentages in the tables are based on revenue. Year Ended December 31, 2024 2023 $ % $ % (in thousands, except percentages) Revenue $ 11,679 100.0 % $ 13,940 100.0 % Cost of revenue 6,833 58.5 7,381 52.9 Gross profit 4,846 41.5 6,559 47.1 Operating expenses: Engineering, research and development 2,052 17.6 2,326 16.7 Selling, general and administrative 4,844 41.5 4,672 33.5 Total operating expenses 6,896 59.0 6,998 50.2 Loss from operations (2,050) (17.6) (439) (3.1) Other income (expense), net 93 0.8 164 1.2 Loss before income taxes (1,957) (16.8) (275) (2.0) Income tax expense 27 0.2 108 0.8 Net loss $ (1,984) (17.0) % $ (383) (2.7) % Comparison of the Years Ended December 31, 2024 and 2023 Revenue by the markets we serve is as follows: Year Ended December 31, 2024 2023 % of % of Amount Revenue Amount Revenue $ Change % Change (in thousands, except percentages) Medical $ 3,926 33.6 % $ 5,210 37.4 % $ (1,284) (24.6) % Industrial 2,631 22.5 4,141 29.7 (1,510) (36.5) Consumer 326 2.8 577 4.1 (251) (43.5) Standard 4,796 41.1 4,012 28.8 784 19.5 Revenue $ 11,679 100.0 % $ 13,940 100.0 % $ (2,261) (16.2) % We sell our custom products into the medical, industrial, and consumer markets.
Biggest changeThe percentages in the tables are based on revenue. Year Ended December 31, 2025 2024 $ % $ % (in thousands, except percentages) Revenue $ 11,890 100.0 % $ 11,679 100.0 % Cost of revenue 7,260 61.1 6,833 58.5 Gross profit 4,630 38.9 4,846 41.5 Operating expenses: Engineering, research and development 1,504 12.6 2,052 17.6 Selling, general and administrative 4,955 41.7 4,844 41.5 Total operating expenses 6,459 54.3 6,896 59.0 Loss from operations (1,829) (15.4) (2,050) (17.6) Other income (expense), net 23 0.2 93 0.8 Loss before income taxes (1,806) (15.2) (1,957) (16.8) Income tax expense (benefit) (191) (1.6) 27 0.2 Net loss $ (1,615) (13.6) % $ (1,984) (17.0) % Comparison of the Years Ended December 31, 2025 and 2024 Revenue by the markets we serve is as follows: Year Ended December 31, 2025 2024 % of % of Amount Revenue Amount Revenue $ Change % Change (in thousands, except percentages) Medical $ 3,629 30.5 % $ 3,926 33.6 % $ (297) (7.6) % Industrial 4,009 33.7 2,631 22.5 1,378 52.3 Automotive 358 30.1 — — 358 100.0 Standard 3,894 32.8 5,122 43.9 (1,228) (24.0) Revenue $ 11,890 100.0 % $ 11,679 100.0 % $ 211 1.8 % We sell our custom products into the medical, industrial, automotive and other specialty markets.
Our effective tax rate is directly affected by the relative proportions of our taxable income in the jurisdictions in which we operate and the applicable tax rates in such jurisdictions.
Our effective tax rate is directly affected by the relative proportions of our taxable income/loss in the jurisdictions in which we operate and the applicable tax rates in such jurisdictions.
We record reserves for potential customer returns and warranty rights. 37 Table of Contents Inventory Valuation Inventories are stated at lower of cost or net realizable value (“NRV”). Inventory costs are determined using standard costs which approximate actual costs under the first-in, first-out method. We evaluate inventories for excess quantities and obsolescence.
We record reserves for potential customer returns and warranty rights. 34 Table of Contents Inventory Valuation Inventories are stated at lower of cost or net realizable value (“NRV”). Inventory costs are determined using standard costs which approximate actual costs under the first-in, first-out method. We evaluate inventories for excess quantities and obsolescence.
Off-Balance Sheet Arrangements As of December 31, 2024 and 2023, we did not have any relationships with unconsolidated entities or financial partnerships, such as entities often referred to as structured finance or special purpose entities, which would have been established for the purpose of facilitating off-balance sheet arrangements or other contractually narrow or limited purposes.
Off-Balance Sheet Arrangements As of December 31, 2025 and 2024, we did not have any relationships with unconsolidated entities or financial partnerships, such as entities often referred to as structured finance or special purpose entities, which would have been established for the purpose of facilitating off-balance sheet arrangements or other contractually narrow or limited purposes.
We sell our standard products to customers in many markets through various distribution networks. The ultimate customer for our standard products may come from different markets which are often unknown to us at the time of sale. Each market has different product design cycles. Products with longer design cycles often have much longer product life cycles.
We sell our standard products to customers in many markets through various distribution networks. The ultimate customer for our products may come from different markets that are often unknown to us at the time of sale. Each market has different product design cycles. Products with longer design cycles often have much longer product life cycles.
Based on the expected mix of domestic and foreign earnings, we anticipate our effective tax rate to remain higher than the U.S. statutory rate of 21% primarily due to a portion of our earnings originating in higher rate jurisdictions of China (25%) and the United Kingdom (25%), offset in part by earnings in lower-rate jurisdictions of Hong Kong (16.5%) and Singapore (17%), while our domestic losses are expected to provide no tax benefit due to the valuation allowance recorded on domestic net operating losses and other deferred tax assets.
Based on the expected mix of domestic and foreign earnings, we anticipate our effective tax rate to remain higher than the U.S. statutory rate of 21% primarily due to a portion of our earnings originating in higher rate jurisdictions of China (25%) and the United Kingdom (25%), offset in part by earnings in the lower-rate jurisdiction of Hong Kong (16.5%), while our domestic losses are expected to provide no tax benefit due to the valuation allowance recorded on domestic net operating losses and other deferred tax assets.
The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. 38 Table of Contents Our foreign subsidiaries are subject to foreign income taxes on earnings in their respective jurisdictions.
The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. 35 Table of Contents Our foreign subsidiaries are subject to foreign income taxes on earnings in their respective jurisdictions.
Recently Issued and Adopted Accounting Pronouncements For a discussion of recently adopted accounting pronouncements, see Recently Issued Accounting Pronouncements in Note 1, The Company and its Significant Accounting Policies , of the notes to the consolidated financial statements appearing elsewhere in this Annual Report on Form 10-K. ITEM 7A.
Recently Issued and Adopted Accounting Pronouncements For a discussion of recently adopted accounting pronouncements, see Recently Issued Accounting Pronouncements in Note 1, The Company and its Significant Accounting Policies , of the notes to the consolidated financial statements appearing elsewhere in this Form 10-K. ITEM 7A.
ITEM 7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS You should read the following discussion and analysis of our financial condition and results of operations in conjunction with the consolidated financial statements and the related notes to the consolidated financial statements included later in this Annual Report on Form 10-K.
ITEM 7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS You should read the following discussion and analysis of our financial condition and results of operations in conjunction with the consolidated financial statements and the related notes to the consolidated financial statements included later in this Form 10-K.
Transactions with Related Parties For a discussion of transactions with related parties, see Note 10, Related Party Transactions , of the notes to the consolidated financial statements, and Item 13, Certain Relationships and Related Transactions, and Director Independence , appearing elsewhere in this Annual Report on Form 10-K.
Transactions with Related Parties For a discussion of transactions with related parties, see Note 10, Related Party Transactions , of the notes to the consolidated financial statements, and Item 13, Certain Relationships and Related Transactions, and Director Independence , appearing elsewhere in this Form 10-K.
For both 2024 and 2023, the Company’s income tax expense reflects tax expense on its foreign earnings with no tax benefit on its domestic losses due to the valuation allowance recorded on domestic net operating losses and other deferred tax assets.
For both 2025 and 2024, the Company’s income tax expense reflects tax expense (or benefit) on its foreign earnings (or losses) with no tax benefit on its domestic losses due to the valuation allowance recorded on domestic net operating losses and other deferred tax assets.
Accounts receivable decreased from $2,167,000 at December 31, 2023 to $1,612,000 at December 31, 2024 due to the timing of shipments and cash collections during the fourth quarter of 2024 compared to the fourth quarter of 2023. Many of our customers pay promptly and accounts receivable is generally related to the most recent shipments.
Accounts receivable decreased from $1,612,000 at December 31, 2024 to $1,542,000 at December 31, 2025 due to the timing of shipments and cash collections during the fourth quarter of 2025 compared to the fourth quarter of 2024. Many of our customers pay promptly and accounts receivable is generally related to the most recent shipments.
QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK Not applicable. 39 Table of Contents
QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK Not applicable. 36 Table of Contents
The balance of these current assets fluctuates with the timing of payments of insurance premiums, advances, and estimated income taxes. Accounts payable, accrued liabilities, and accrued income taxes decreased from $1,249,000 at December 31, 2023 to $1,038,000 at December 31, 2024.
The balance of these current assets fluctuates with the timing of payments of insurance premiums, advances, and estimated income taxes. Accounts payable, accrued liabilities, and accrued income taxes increased from $1,038,000 at December 31, 2024 to $1,339,000 at December 31, 2025.
Cash and cash equivalents consist of cash and money market funds. We did not have any short-term or long-term investments as of December 31, 2024. Of our $3.0 million of cash, $1.8 million was held by foreign subsidiaries.
Cash and cash equivalents consist of cash and money market funds. We did not have any short-term or long-term investments as of December 31, 2025. Of our $2.7 million of cash, $2.1 million was held by foreign subsidiaries.
Inventories decreased from $2,476,000 at December 31, 2023 to $2,009,000 at December 31, 2024 due primarily to variability in the timing of materials purchases and customer demand on product shipments. Prepaid expenses and other current assets decreased slightly from $381,000 at December 31, 2023 to $328,000 at December 31, 2024.
Inventories decreased from $2,009,000 at December 31, 2024 to $1,801,000 at December 31, 2025 due primarily to variability in the timing of materials purchases and customer demand on product shipments. Prepaid expenses and other current assets decreased from $328,000 at December 31, 2024 to $236,000 at December 31, 2025.
Other income (expense), net for 2024 was comprised of $54,000 of interest income and $39,000 of foreign currency transaction gains, while other income (expense), net for 2023 was comprised of $155,000 of interest income, $3,000 of foreign currency transaction gains, and $6,000 of other non-operating income. Year Ended December 31, 2024 2023 Change % of % of in % of Pre-tax Pre-tax Pre-tax Amount Income Amount Income $ Change Income (in thousands, except percentages) Income tax expense $ 27 1.4 % $ 108 39.3 % $ (81) (37.9) Income tax expense reflects statutory tax rates in the jurisdictions in which we operate on the taxable income (loss) we generate in each jurisdiction.
Other income (expense), net for 2025 was comprised of $20,000 of interest income and $3,000 of foreign currency transaction gains, while other income (expense), net for 2024 was comprised of $54,000 of interest income and $39,000 of foreign currency transaction gains. Year Ended December 31, 2025 2024 Change % of % of in % of Pre-tax Pre-tax Pre-tax Income/ Income/ Income/ Amount Loss Amount Loss $ Change Loss (in thousands, except percentages) Income tax expense (benefit) $ (191) 10.6 % $ 27 1.4 % $ (218) 9.2 % Income tax expense reflects statutory tax rates in the jurisdictions in which we operate on the taxable income (loss) we generate in each jurisdiction.
Cash Flow Analysis Our cash flows from operating, investing and financing activities are summarized as follows: Year Ended December 31, 2024 2023 (in thousands) Net cash (used in) operating activities $ (367) $ (116) Net cash (used in) investing activities (491) (4,885) Net cash (used in) financing activities (400) (750) Net Cash (Used In) Operating Activities For the year ended December 31, 2024, the $367,000 in net cash used in operating activities was attributable to net loss of $1,984,000, adjusted for non-cash charges of $809,000 and cash provided by changes in operating assets and liabilities of $808,000.
Cash Flow Analysis Our cash flows from operating, investing and financing activities are summarized as follows: Year Ended December 31, 2025 2024 (in thousands) Net cash (used in) operating activities $ (112) $ (367) Net cash (used in) investing activities (56) (491) Net cash (used in) financing activities (91) (400) Net Cash (Used In) Operating Activities For the year ended December 31, 2025, the $112,000 in net cash used in operating activities was attributable to net loss of $1,615,000, adjusted for non-cash charges of $519,000 and cash provided by changes in operating assets and liabilities of $984,000.
In all markets, the timing of orders from our customers is not always predictable and can be less in some periods and higher in others depending on their projects and building plans. Year Ended December 31, 2024 2023 % of % of Amount Revenue Amount Revenue $ Change % Change (in thousands, except percentages) Gross profit $ 4,846 41.5 % $ 6,559 47.1 % $ (1,713) (26.1) % Our gross profit and gross margin percentage are impacted by various factors including product mix, customer mix, sales volume, and fluctuations in our cost of revenues, which are comprised of material costs, direct and indirect production labor costs, warehousing and logistics costs, facilities costs, and other costs related to production activities.
In all markets, the timing of orders from our customers is not always predictable and can vary significantly from period to period depending on customers’ projects and building plans. Year Ended December 31, 2025 2024 % of % of Amount Revenue Amount Revenue $ Change % Change (in thousands, except percentages) Gross profit $ 4,630 38.9 % $ 4,846 41.5 % $ (216) (4.5) % Our gross profit and gross margin percentage are impacted by various factors including product mix, customer mix, sales volume, and fluctuations in our cost of revenues, which are comprised of material costs, direct and indirect production labor costs, warehousing and logistics costs, facilities costs, and other costs related to production activities.
Engineering and R&D costs for 2024 were down compared to the prior year due primarily to decreased engineering employee headcount, offset in part by increased prototyping and product-development activities this year as compared to the prior year. Year Ended December 31, 2024 2023 % of % of Amount Revenue Amount Revenue $ Change % Change (in thousands, except percentages) Selling, general and administrative $ 4,844 41.5 % $ 4,672 33.5 % $ 172 3.7 % Selling, general and administrative expenses consist primarily of compensation expenses, legal and other professional fees, facilities expenses and communication expenses.
Engineering and R&D costs for 2025 were down compared to the prior year due primarily to lower engineering employee headcount and lower consultant and outside services costs, offset in part by higher costs on prototyping and product-development activities. Year Ended December 31, 2025 2024 % of % of Amount Revenue Amount Revenue $ Change % Change (in thousands, except percentages) Selling, general and administrative $ 4,955 41.7 % $ 4,844 41.5 % $ 111 2.3 % Selling, general and administrative expenses consist primarily of compensation expenses, legal and other professional fees, facilities expenses and communication expenses.
We currently have products with life cycles that have exceeded 20 years and are ongoing. 33 Table of Contents Revenues were down in 2024 compared to 2023 to customers in all of the custom markets we sell to, and were up to customers of our standard products.
We currently have products with life cycles that have exceeded 20 years and are ongoing. 30 Table of Contents Revenues were up in 2025 compared to 2024 to customers in the industrial and automotive markets, and were down to customers in the medical market and to customers of our standard products.
Liquidity and Capital Resources Cash requirements for working capital, capital expenditures, and acquisition activities have been funded from our cash balances, cash generated from operations and sales of marketable securities, and issuances of equity securities. As of December 31, 2024, we had cash and cash equivalents of $3.0 million, working capital of $5.5 million and no indebtedness.
Liquidity and Capital Resources Cash requirements for working capital, capital expenditures, and acquisition activities have historically been funded from our cash balances, cash generated from operations, and issuances of equity securities. As of December 31, 2025, we had cash and cash equivalents of $2.7 million, working capital of $4.6 million and no indebtedness.
Net cash used in financing activities of $750,000 for the year ended December 31, 2023 consisted of payment of $400,000 of dividends on our Preferred Stock, and $350,000 used for repurchases of 56,430 shares of common stock.
Net cash used in financing activities for the year ended December 31, 2024 consisted of payment of $400,000 of dividends on our Preferred Stock.
For the year ended December 31, 2023, the $116,000 in net cash used in operating activities was attributable to net loss of $383,000, adjusted for non-cash charges of $806,000 and cash used in changes in operating assets and liabilities of $539,000.
For the year ended December 31, 2024, the $367,000 in net cash used in operating activities was attributable to net loss of $1,984,000, adjusted for non-cash charges of $809,000 and cash provided by changes in operating assets and liabilities of $808,000.
Factors that could cause or contribute to these differences include those discussed below and elsewhere in this Annual Report on Form 10-K, particularly in “Risk Factors” and “Special Note Regarding Forward-Looking Statements.” Overview Interlink Electronics, Inc. is a leading provider of sensors and printed electronics used extensively in HMI devices and IoT solutions.
Factors that could cause or contribute to these differences include those discussed below and elsewhere in this Form 10-K, particularly in “Risk Factors” and “Special Note Regarding Forward-Looking Statements.” Executive Overview Interlink Electronics, Inc. is a leading global provider of advanced sensing technologies and printed electronics solutions that enable Human-Machine Interface (“HMI”) devices and Internet-of-Things (“IoT”) applications.
Selling, general and administrative expenses for the current year were up compared to last year due primarily to the inclusion of Calman for the full year of 2024 (versus only the March to December period of 2023). Year Ended December 31, 2024 2023 % of % of Amount Revenue Amount Revenue $ Change % Change (in thousands, except percentages) Other income (expense), net $ 93 0.8 % $ 164 1.2 % $ (71) (43.3) 34 Table of Contents Other income (expense), net consists of non-operating income and expenses, such as gains and losses on marketable securities, foreign currency transaction gains and losses, interest income and expense, and other non-operating income and expenses.
Selling, general and administrative expenses for the current year were up slightly compared to last year due primarily to the inclusion of Conductive Transfers in 2025 (which was acquired in December 2024), offset in part by lower sales and administrative compensation expense on lower headcount elsewhere. Year Ended December 31, 2025 2024 % of % of Amount Revenue Amount Revenue $ Change % Change (in thousands, except percentages) Other income (expense), net $ 23 0.2 % $ 93 0.8 % $ (70) (7.5) % 31 Table of Contents Other income (expense), net consists of non-operating income and expenses, such as gains and losses on marketable securities, foreign currency transaction gains and losses, interest income and expense, and other non-operating income and expenses.
If our circumstances change, however, we may require additional cash. If we require additional cash, we may attempt to raise additional capital through equity, equity-linked or debt financing arrangements. If we raise additional funds by issuing equity or equity-linked securities, the ownership of our existing stockholders will be diluted.
If we raise additional funds by issuing equity or equity-linked securities, the ownership of our existing stockholders will be diluted.
Gross profit for 2024 was down compared to 2023 due to lower revenue on lower customer demand, while gross margin percentage was down due primarily to the impact the largely fixed portion of our manufacturing- and production-related cost of revenue has on our gross margin percentage, in addition to changes in product and customer mix. Year Ended December 31, 2024 2023 % of % of Amount Revenue Amount Revenue $ Change % Change (in thousands, except percentages) Engineering, research and development $ 2,052 17.6 % $ 2,326 16.7 % $ (274) (11.8) % Engineering and R&D expenses consist primarily of compensation expenses for employees engaged in research, design and product development activities, and the cost of those employees’ indirect supplies and allocation of facilities expenses.
Gross profit and gross margin percentage for 2025 were down compared to 2024 due primarily to changes in the mix of products sold, and also in part due to strengthened Chinese yuan relative to the U.S. dollar which increased the cost of our production activities in China. Year Ended December 31, 2025 2024 % of % of Amount Revenue Amount Revenue $ Change % Change (in thousands, except percentages) Engineering, research and development $ 1,504 12.6 % $ 2,052 17.6 % $ (548) (26.7) % Engineering and R&D expenses consist primarily of compensation expenses for employees engaged in research, design and product development activities and the cost of those employees’ indirect supplies and allocation of facilities expenses.
The balance of these current liabilities fluctuates based on the timing of payment for purchases of materials, compensation accruals, outside services, and income taxes.
The balance of these current liabilities fluctuates based on the timing of payment for purchases of materials, compensation accruals, outside services, and income taxes. Net Cash (Used In) Investing Activities Net cash used in investing activities for the year ended December 31, 2025 consisted of $56,000 used for purchases of property and equipment.
Medical, industrial, and environmental monitoring products generally have longer design and life cycles than consumer products.
Medical, industrial, and other specialty markets such as environmental monitoring products generally have long design and life cycles.
Net Cash (Used In) Investing Activities Net cash used in investing activities of $491,000 for the year ended December 31, 2024 consisted of $314,000 used to acquire the assets of Conductive Transfers in December 2024, and $177,000 used for purchases of property and equipment.
Net cash used in investing activities of $491,000 for the year ended December 31, 2024 consisted of $314,000 used to acquire the assets of Conductive Transfers in December 2024, and $177,000 used for purchases of property and equipment. 33 Table of Contents Net Cash (Used In) Financing Activities Net cash used in financing activities of $91,000 for the year ended December 31, 2025 consisted of proceeds of $242,000 from issuance of Common Stock (net of $86,000 of offering costs), offset by payment of $333,000 of dividends on our Preferred Stock.
However, our intent is to permanently reinvest these funds outside the U.S. and our current plans do not demonstrate a need to repatriate cash. We have outstanding 200,000 shares of our 8.0% Series A Convertible Preferred Stock (the “Preferred Stock”) that have an aggregate liquidation preference of $5.0 million.
However, our intent is to permanently reinvest these funds outside the U.S. and our current plans do not demonstrate a need to repatriate cash. 32 Table of Contents In October 2025, we converted our Series A Convertible Preferred Stock into Common Stock, which eliminated the 8.0% per annum cumulative cash dividend payable on the Preferred Stock, for a cash savings of $400,000 per year.
The decrease in revenue from customers in all custom markets was due to decreased shipments of our force-sensing and gas-sensing products and solutions resulting from lower customer demand in 2024 compared to 2023.
The decrease in revenue from customers in the medical market was due to lower shipments of our traditional force-sensing products offset in part by higher shipments of our Calman printed electronics, all of which is driven by customer demand.
We also plan to explore potential strategic relationships with companies and technology institutes that will support our growth initiatives. Results of Operations The following table sets forth certain consolidated statements of operations data for the periods indicated.
Results of Operations The following table sets forth certain consolidated statements of operations data for the periods indicated.
We entered the gas and environmental sensing market in 2022 through our acquisition of the business assets of SPEC and KWJ, early pioneers in miniaturized, low-cost gas and environmental sensing technologies.
We are increasingly positioning our HMI offerings as integrated subsystems that combine sensing hardware with proprietary firmware, signal processing, and system-level design. Gas and Environmental Sensing Solutions . We entered the gas and environmental sensing market in 2022 through the acquisition of the assets of SPEC Sensors and KWJ Engineering.